Form4insider filings, from the source

SEC Form 4 · accession 0001645627-17-000007

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Dec 28, 2016
Accepted (ET)
Feb 28, 2017 · 6:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockDec 28, 2016P1,000$0.0578A19,617,315D
Common StockDec 28, 2016P500$0.0564A19,617,815D
Common StockDec 28, 2016P200$0.057A19,618,015D
Common StockDec 29, 2016P200$0.0553A19,618,215D
Common StockDec 29, 2016P200$0.0531A19,618,415D
Common StockDec 29, 2016P200$0.0544A19,618,615D
Common StockDec 29, 2016P200$0.0544A19,618,815D
Common StockDec 29, 2016P200$0.0549A19,619,015D
Common StockDec 30, 2016P50$0.0501A19,619,065D
Common StockDec 30, 2016P150$0.0509A19,619,215D
Common StockDec 30, 2016P1,000$0.0501A19,620,215D
Common StockDec 30, 2016P200$0.0509A19,620,415D
Common StockDec 30, 2016P150$0.05A19,620,565D
Common StockDec 30, 2016P50$0.0509A19,620,615D
Common StockDec 30, 2016P200$0.051A19,620,815D
Common StockDec 30, 2016P200$0.051A19,621,015D
Common StockDec 30, 2016P200$0.0506A19,621,215D
Common StockDec 30, 2016P200$0.0494A19,621,415D
Common StockDec 30, 2016P200$0.05A19,621,615D
Common StockDec 30, 2016P50$0.0494A19,621,665D
Common StockDec 30, 2016P150$0.0499A19,621,815D
Common StockDec 30, 2016P1,000$0.0494A19,622,815D
Common StockDec 30, 2016P50$0.0494A19,622,865D
Common StockDec 30, 2016P150$0.0499A19,623,015D
Common StockJan 3, 2017P200$0.0599A19,623,215D
Common StockJan 3, 2017P200$0.0599A19,623,415D
Common StockJan 3, 2017P200$0.051A19,623,615D
Common StockJan 3, 2017P1,000$0.0504A19,624,615D
Common StockJan 3, 2017P100$0.051A19,624,715D
Common StockJan 3, 2017P200$0.0499A19,624,915D

Table II — derivative securities

No Table II lines on this filing.